Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era

Theodoros P. Vassilakopoulos, Fotios Panitsas, Zois Mellios, John Apostolidis, Alexia Piperidou, Michalis D Michael, Ronit Gurion, Meltem Akay, Eleftheria Hatzimichael, Stamatis J. Karakatsanis, Maria Dimou, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ioannis Kotsianidis, Chara Giatra, Nikolaos Kanellias, Ayman Sayyed, Tamar Tadmor, Leylagul Kaynar, Miri Zektser, Argiris Symeonidis, SC Atalar, Evgenia Verrou, Odit Gutwein, Chezi Ganzel, Giorgos Karianakis, Jonathan Isenberg, Gabriela Gainaru, Theodora Triantafyllou, Efimia Vrakidou, Maria Palassopoulou, Mehmet Ozgur, Semra Paydas, Panagiotis Tsirigotis, Maria Tsirogianni, Tulin Tuglular, Chrysovalantou Chatzidimitriou, Maria Kotsopoulou, Evangelos Terpos, Panagiotis Zikos, Argyro Koumarianou, Christos Poziopoulos, Dimitrios Boutsis, Anat Gafter-Gvili, Themistoklis Karmiris, Maria K. Angelopoulou, Maria Bakiri Papaioannou, Gerassimos Pangalis, Panayiotis Panayiotidis, Burhan Ferhanoglu, Netanel A. Horowitz, Sotirios Papageorgiou

Blood (2022) 140 (Supplement 1): 9554–9556.

https://doi.org/10.1182/blood-2022-168627

Published: 2022

Journal Articles

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment

Blood (2022) 140 (Supplement 1): 8503–8504.

https://doi.org/10.1182/blood-2022-158549

Published: 2022

Journal Articles

Plasmic and Plasic Αre Εxcellent Predictors of Severe ADAMTS13 Deficiency in Thrombotic Microangiopathy Patients without Secondary Causes

Blood (2019) 134 (Supplement_1): 4913.

https://doi.org/10.1182/blood-2019-125343

Published: 2019

Journal Articles

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Blood (2018) 132 (6): 666–670.

https://doi.org/10.1182/blood-2018-02-833608

Published: 2018

Journal Articles

Real-World Data on Clinical Characteristics, Prognosis and Outcome of Primary Plasma Cell Leukemia: A Study of the Greek Myeloma Study Group in the Era of Novel Agents

Blood (2016) 128 (22): 4490.

https://doi.org/10.1182/blood.V128.22.4490.4490

Published: 2016

Journal Articles

Bone Marrow Derived Mesenchymal Stem Cells from Splenic Marginal Zone Lymphoma Patients Exhibit Altered Proliferative Potential and B Lymphocyte Immunomodulatory Properties

Athanasia Kalyva, PhD, Charalampos Pontikoglou, MD PhD, Christina Kalpadakis, MD PhD, Athina Trakaki, Nikitas Zorzos, Maria Velegraki, MD PhD, Grigorios Panteloglou, Kallliopi Alpantaki, MDPhD, Gerasimos A. Pangalis, MD PhD, Helen A Papadaki, MDPhD

Blood (2015) 126 (23): 2396.

https://doi.org/10.1182/blood.V126.23.2396.2396

Published: 2015

Journal Articles

Unique Versus Common: Disease-Biased Immunoglobulin Gene Repertoires Along with Public Antigen Receptor Stereotypes in Marginal Zone B-Cell Lymphoproliferations

Blood (2015) 126 (23): 1479.

https://doi.org/10.1182/blood.V126.23.1479.1479

Published: 2015

Journal Articles

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Blood (2014) 123 (8): 1199–1206.

https://doi.org/10.1182/blood-2013-07-515155

Published: 2014

Journal Articles

Increased Immunohistochemical CD138 Expression in Waldenström's Macroglobulinemia (WM) in Comparison with Splenic Marginal Zone Lymphoma (SMZL).

Tatiana K Tzenou, G.A. Pangalis, Georgia Levidou, Christina Kalpadakis, Spyros Siakavellas, Dimitrios Maltezas, Efstathios Koulieris, Maria Dimou, Vasiliki Bartzi, Georgios Georgiou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Styliani Kokkoris, Penelope Korkolopoulou, Athina Androulaki, Eystathios Patsouris, Panayiotis Panayiotidis, Marie-Christine Kyrtsonis

Blood (2009) 114 (22): 5008.

https://doi.org/10.1182/blood.V114.22.5008.5008

Published: 2009

Journal Articles

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Blood (2007) 110 (11): 1490.

https://doi.org/10.1182/blood.V110.11.1490.1490

Published: 2007

Journal Articles

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Nicoletta Kafasi, MD, Sotirios Sachanas, MD, Tatiana Tzenou, MD, Argiroula Papadogiannis, MD, Zacharoula Galanis, MD, Christina Kalpadakis, MD, Maria Dimou, MD, Elias Kyriakou, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 3522.

https://doi.org/10.1182/blood.V108.11.3522.3522

Published: 2006

Journal Articles

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Maria K. Angelopoulou, MD, Maria Papakonstantinou, MD, Flora N. Kontopidou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani Kokoris, MD, Evangelia M. Dimitriadou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Padelis Tsirkinidis, MD, Marie-Christine Kyrtsonis, MD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4655.

https://doi.org/10.1182/blood.V108.11.4655.4655

Published: 2006

Journal Articles

Efficacy of Rituximab in Hairy Cell Leukemia.

Styliani I. Kokoris, Maria K. Angelopoulou, Zacharoula I. Galani, Konstantinos Anargyrou, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Marina P. Siakantaris, Flora N. Kontopidou, Evangelia M. Dimitriadou, Maria N. Dimopoulou, Panayiotis Tsaftaridis, Eleni Plata, Christina Kalpadakis, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4719.

https://doi.org/10.1182/blood.V108.11.4719.4719

Published: 2006

Journal Articles

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Christina Kalpadakis, MD, Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Maria N. Dimopoulou, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Maria K. Angelopoulou, MD, Fotios Mitropoulos, MD, Penelope Korkolopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4785.

https://doi.org/10.1182/blood.V106.11.4785.4785

Published: 2005

Journal Articles

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Argyro Papadogiannis, MD, Marie-Cristine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Antonios G. Antoniadis, MD, Christina Kalpadakis, MD, Sotirios Sachanas, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos Pangalis, MD

Blood (2005) 106 (11): 5074.

https://doi.org/10.1182/blood.V106.11.5074.5074

Published: 2005

Journal Articles

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Marie-Christine Kyrtsonis, MD, Sotirios Sachanas, MD, Theodoros P. Vassilakopoulos, MD, Nikoletta Kafassi, MD, Tatiana Tzenou, MD, Argyro Papadogiannis, MD, Christina Kalpadakis, MD, Antonios G. Antoniadis, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5193.

https://doi.org/10.1182/blood.V106.11.5193.5193

Published: 2005

Journal Articles

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Argyro Papadogiannis, MD, Tatiana Tzenou, MD, Christina Kalpadakis, MD, Antoine Antoniadis, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Stella I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Ellen Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 3404.

https://doi.org/10.1182/blood.V106.11.3404.3404

Published: 2005

Journal Articles

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Andreas Katsigiannis, MD, Maria N. Dimopoulou, MD, Styliani I. Kokoris, MD, Evridiki Michalis, MD, Evangelia M. Dimitriadou, MD, Marina P. Siakantaris, MD, Flora N. Kontopidou, MD, Christina Kalpadakis, MD, Angelos Sarantopoulos, MD, Pinelopi Korkolopoulou, MD, Paraskevi Roussou, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 935.

https://doi.org/10.1182/blood.V106.11.935.935

Published: 2005

Journal Articles

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Maria N. Dimopoulou, MD, Christina Kalpadakis, MD, Evangelia M. Dimitriadou, MD, Marie-Christine Kyrtsonis, MD, Styliani I. Kokoris, MD, Panagiotis Tsaftaridis, MD, Flora N. Kontopidou, MD, Marina P. Siakantaris, MD, Eleni Plata, MD, Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4800.

https://doi.org/10.1182/blood.V106.11.4800.4800

Published: 2005

Journal Articles

Molecular Analysis of the VH Gene Usage in a Familial Case of Waldenstrom’s Macroglobulinemia.

Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Konstantinos Lilakos, Maria K. Angelopoulou, MD, S. Vavourakis, MD, Flora N. Kontopidou, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Constantin Kilindireas, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 1005.

https://doi.org/10.1182/blood.V106.11.1005.1005

Published: 2005

NARROW

Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment

Plasmic and Plasic Αre Εxcellent Predictors of Severe ADAMTS13 Deficiency in Thrombotic Microangiopathy Patients without Secondary Causes

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Real-World Data on Clinical Characteristics, Prognosis and Outcome of Primary Plasma Cell Leukemia: A Study of the Greek Myeloma Study Group in the Era of Novel Agents

Bone Marrow Derived Mesenchymal Stem Cells from Splenic Marginal Zone Lymphoma Patients Exhibit Altered Proliferative Potential and B Lymphocyte Immunomodulatory Properties

Unique Versus Common: Disease-Biased Immunoglobulin Gene Repertoires Along with Public Antigen Receptor Stereotypes in Marginal Zone B-Cell Lymphoproliferations

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Increased Immunohistochemical CD138 Expression in Waldenström's Macroglobulinemia (WM) in Comparison with Splenic Marginal Zone Lymphoma (SMZL).

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Efficacy of Rituximab in Hairy Cell Leukemia.

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Molecular Analysis of the VH Gene Usage in a Familial Case of Waldenstrom’s Macroglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only